SXTC: SXT Pharmaceuticals Kapitalizatsiyaning daromadga nisbati

SXT China (SXTC) kompaniyasining korporativ logotipi

China SXT Pharmaceuticals (SXTC) Xitoy tabibligi uchun yopiq ishlab chiqarish siklini saqlaydi va dalalardan dorixonalargacha bo'lgan butun zanjirni nazorat qiladi. GURU.Markets platformasidagi kompaniyaga tegishli ushbu P/S grafigi bozor baholashini aks ettiradi, bunda 0.30 qiymati metrika darajasini ifodalaydi. Kooperativlar orqali xomashyoni moslashuvchan tarzda tashqi manbalardan jalb qilish xatarlarni minimallashtiradi, generiklar nishasidagi o'rtacha narx belgilash imkoniyati esa haddan tashqari yuqori ustamalarning o'sishini jilovlaydi.

SXTC: SXT China P/S multiplikatori 04.07.2022 - 15.11.2026

sxtchina.com (SXTC) kompaniyasining tahliliy kesimlari

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning jamlanma tahliliyoti:China SXT Pharmaceuticals, SXTC
China SXT Pharmaceuticals tomonidan chiqariladigan mahsulotlar

Investorlar China SXT Pharmaceuticals (SXTC) kompaniyasining barqarorligini biznesning bozor qiymati va yillik aylanmasi nisbati orqali bahlamoqdalar. Ushbu narxning savdoga nisbati (price-to-sales) ko'rsatkichi daromadning har bir birligiga qancha kapitalizatsiya dollari to'g'ri kelishini o'lchaydi va bu an'anaviy o'simliklarga asoslangan dori vositalarining barqaror savdosi uchun to'langan premiumni aniqlash imkonini beradi. Ushbu grafik tahlili aksiyalarining joriy past baholanishi bozor xavfi natijasi yoki yashirin kirish imkoniyati ekanligini aniqlashga yordam beradi.

China SXT Pharmaceuticals raqobatchilari

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Narxning daromadga nisbati|Perrigo Company PLC - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati alvotech.com|P/S multiplikatori Liquidia Technologies|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corp)|Narx/daromad koeffitsiyenti Amphastar (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|SPRY - P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning daromadga nisbati|SCPH (scpharmaceuticals.com) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|EPRX: Narxning sotuvga nisbati|BioHarvest Sciences - Kapitalizatsiyaning daromadga nisbati|EXOZ: Kapitalizatsiya va daromad nisbati|ORMP - Narxning daromadga nisbati|ENTX: Narxning daromadga nisbati|HYFT: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S multiplikatori|P/S multiplikatori quantumbiopharma.com|P/S multiplikatori FGEN|Kapitalizatsiyaning daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|P/S multiplikatori RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Narxning sotuvga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|lexariabioscience.com (LEXX) - Kapitalizatsiyaning daromadga nisbati|Pulmatrix Inc (PULM) - Narxning daromadga nisbati|PTHL: Kapitalizatsiyaning sotish hajmiga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)